WallStSmart
VCEL

Vericel Corp Ord

NASDAQ: VCEL · HEALTHCARE · BIOTECHNOLOGY

$33.43
-6.23% today

Updated 2026-04-29

Market cap
$1.82B
P/E ratio
111.41
P/S ratio
6.57x
EPS (TTM)
$0.32
Dividend yield
52W range
$29 – $46
Volume
0.6M

Vericel Corp Ord (VCEL) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
-17.9%
Last 4 quarters
Revenue YoY growth
+23.3%
Most recent quarter
EPS YoY growth
+18.4%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-3.8%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-12.4%
2025-07-31
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-26$0.45+14.3%$37.09$35.68-3.8%
2025-11-06$0.10+1100.0%$37.20$38.94+4.7%
2025-07-31$-0.01+66.7%$40.66$35.63-12.4%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.39$0.45+14.3%$92.92M+23.3%
2025-09-30$-0.01$0.10+1100.0%$67.50M+16.6%
2025-06-30$-0.03$-0.01+66.7%$63.24M+20.1%
2025-03-31$-0.15$-0.23-50.0%$52.60M+2.6%
2024-12-31$0.34$0.38+11.8%$75.38M+16.0%
2024-09-30$-0.05$-0.02+60.0%$57.91M+27.0%
2024-06-30$-0.08$-0.10-25.0%$52.66M+14.7%
2024-03-31$-0.11$-0.08+27.3%$51.28M+25.0%
2023-12-31$0.17$0.26+52.9%$65.00M
2023-09-30$-0.12$-0.08+33.3%$45.58M
2023-06-30$-0.15$-0.11+26.7%$45.92M
2023-03-31$-0.15$-0.16-6.7%$41.02M

Frequently asked questions

Has Vericel Corp Ord beaten earnings estimates?
Vericel Corp Ord has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of -17.9% over the last 2 quarters.
How does VCEL stock react to earnings?
VCEL stock has moved an average of -3.8% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Vericel Corp Ord's revenue growth rate?
Vericel Corp Ord reported year-over-year revenue growth of +23.3% in its most recent quarter, with EPS growing +18.4% year-over-year.